デフォルト表紙
市場調査レポート
商品コード
1441239

静脈内輸液ポンプの世界市場規模、シェア、成長分析、製品別、適応疾患別-産業予測、2023~2030年

Global Intravenous Infusion Pump Market Size, Share, Growth Analysis, By By Product(Volumetric Infusion Pumps, Insulin Infusion Pumps), By By Disease Indication(Chemotherapy, Diabetes) - Industry Forecast 2023-2030

出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
静脈内輸液ポンプの世界市場規模、シェア、成長分析、製品別、適応疾患別-産業予測、2023~2030年
出版日: 2024年02月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

静脈内輸液ポンプの世界市場規模は、2022年に53億米ドルと評価され、2023年の57億4,000万米ドルから2031年には108億6,000万米ドルに成長し、予測期間中(2024~2031年)のCAGRは8.3%で成長する展望です。

静脈内輸液ポンプの世界市場は、慢性疾患の有病率の増加、高齢者人口の急増、医療技術の進歩に起因して、大幅な成長を示しています。これらのポンプは、輸液、薬物、栄養素を患者の静脈に正確かつ制御しながら直接送り込む上で極めて重要な役割を果たしています。この市場拡大の主要促進要因としては、在宅医療サービス、特に持続的輸液療法に対する需要の高まり、臨床環境における正確な薬剤投与の必要性などが挙げられます。さらに、投薬ミスを軽減し、患者の安全性を高め、治療成績を向上させる取り組みも、市場の勢いに寄与しています。輸液ポンプ市場の今後の動向は、患者の安全性と治療効果を最優先とした直感的で相互接続性の高い機器の市場開拓に加え、医療従事者と患者双方の進化する要件を満たすためのデータ主導型技術と患者中心の設計の継続的な統合にかかっています。

目次

エグゼクティブサマリー

  • 市場概要
  • 繁栄と衰退

調査手法

  • 情報調達
  • セカンダリとプライマリデータソース
  • 市場規模の推定
  • 市場の前提条件と制限

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主要市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主要投資の分析
  • 主要成功要因
  • 競合の程度

市場力学と展望

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

静脈内輸液ポンプの世界市場:製品別

  • 市場概要
  • 容積式輸液ポンプ
  • インスリン輸液ポンプ
  • シリンジ輸液ポンプ
  • 経腸輸液ポンプ
  • 携帯用輸液ポンプ
  • 患者管理鎮痛法(PCA)
  • 植込み型輸液ポンプ
  • その他

静脈内輸液ポンプの世界市場:適応疾患別

  • 市場概要
  • 化学療法
  • 糖尿病
  • 消化器科
  • 鎮痛/疼痛管理
  • 小児科・新生児科
  • 血液
  • その他

静脈内輸液ポンプの世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他の欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2021年)
  • 主要市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2021年)

主要企業プロファイル

  • Becton, Dickinson and Company(米国)
  • B. Braun Melsungen AG(ドイツ)
  • Fresenius Kabi AG(ドイツ)
  • Baxter International Inc.(米国)
  • Medtronic plc(アイルランド)
  • Johnson & Johnson(米国)
  • Terumo Corporation(日本)
  • ICU Medical, Inc.(米国)
  • Smiths Medical(米国)
  • Roche Holding AG(スイス)
  • Moog Inc.(米国)
  • Nipro Corporation(日本)
  • Zyno Medical(米国)
  • Mindray Medical International Limited(中国)
  • Teleflex Incorporated(米国)
  • Hospira, Inc.(米国)
  • Halyard Health, Inc.(米国)
  • Smiths Group plc(英国)
  • Vygon Group(フランス)
  • Micrel Medical Devices SA(ギリシャ)
  • Caesarea Medical Electronics Ltd.(イスラエル)
  • Sino Medical-Device Technology Co., Ltd.(中国)
  • Tricumed Medizintechnik GmbH(ドイツ)
  • Coopdech(タイ)
  • Q Core Medical Ltd.(イスラエル)
目次
Product Code: SQMIG35A2492

Global Intravenous Infusion Pump Market size was valued at USD 5.3 billion in 2022 and is poised to grow from USD 5.74 billion in 2023 to USD 10.86 billion by 2031, growing at a CAGR of 8.3% during the forecast period (2024-2031).

The global market for intravenous (IV) infusion pumps has witnessed substantial growth, attributed to the increasing prevalence of chronic illnesses, a burgeoning elderly population, and advancements in medical technology. These pumps play a pivotal role in delivering fluids, medications, and nutrients directly into patients' veins with precision and control. Key drivers of this market expansion include the growing demand for home healthcare services, especially for continuous infusion therapies, and the imperative for precise drug administration in clinical environments. Additionally, efforts to mitigate medication errors, enhance patient safety, and improve treatment outcomes contribute to market momentum. The future trajectory of the IV infusion pump market hinges on the development of intuitive, interconnected devices prioritizing patient safety and treatment efficacy, as well as the ongoing integration of data-driven technologies and patient-centered designs to meet the evolving requirements of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Infusion Pump Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Infusion Pump Market Segmental Analysis

The Global Intravenous Infusion Pump Market is segmented on the basis of Product, Disease Indication, and region. By Product, the market is segmented into Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia (PCA), Implantable Infusion Pumps, Others. By Disease Indication, the market is segmented into Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Intravenous Infusion Pump Market

The rising occurrence of chronic conditions like cancer, diabetes, and cardiovascular ailments, combined with a worldwide aging demographic, fuels the necessity for intravenous (IV) infusion pumps. These tools play a vital role in precisely delivering medications, fluids, and nutrients to patients undergoing extended treatments, thereby enhancing disease control and fostering better patient results.

Restraints in the Global Intravenous Infusion Pump Market

Advanced intravenous infusion pumps, though highly effective, may pose significant financial challenges due to their expensive acquisition and maintenance costs, including calibration, upkeep, and training expenses. Such financial burdens can significantly strain healthcare budgets, posing a formidable barrier for healthcare facilities, especially in resource-limited settings or areas with constrained financial resources dedicated to healthcare.

Market Trends of the Global Intravenous Infusion Pump Market

The surge in Smart and Connected Infusion Pumps, which amalgamate technology and connectivity, marks a notable advancement in intravenous infusion systems. These intelligent pumps provide functionalities like dose calculation aid, seamless wireless integration with electronic health records (EHR) systems, and live monitoring of infusion metrics. This trend not only elevates patient safety but also enhances healthcare provider workflow efficiency, enabling remote monitoring and adjustments. The momentum towards digital healthcare solutions has spurred the uptake of smart infusion pumps, promising to mitigate medication errors and optimize the administration process.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Intravenous Infusion Pump Market by By Product

  • Market Overview
  • Volumetric Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Pumps
  • Enteral Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient Controlled Analgesia (PCA)
  • Implantable Infusion Pumps
  • and Others

Global Intravenous Infusion Pump Market by By Disease Indication

  • Market Overview
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • and Others

Global Intravenous Infusion Pump Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Moog Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zyno Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mindray Medical International Limited (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hospira, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Halyard Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vygon Group (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Micrel Medical Devices SA (Greece)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caesarea Medical Electronics Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sino Medical-Device Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tricumed Medizintechnik GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coopdech (Thailand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Q Core Medical Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments